Effect of automated peritoneal dialysis in uremic patients with COVID-19 infection
Objective:To observe the effect of automated peritoneal dialysis(APD)in uremic patients with COVID-19 infection.Methods:From December 7,2022 to January 20,2023,34 regular peritoneal dialysis patients hospitalized in the Department of Nephrology,Sichuan People's Hospital due to COVID-19 infection were selected.According to the condition and voluntary principle,16 patients were selected for continuous ambulatory peritoneal dialysis(CAPD)treatment(CAPD group),and 18 patients were selected for APD treatment(APD group).The biochemical indicators,ultrafiltration volume,and hospital costs etc.were compared between the two groups.Results:The hospitalization expenses of the APD group were lower than those of the CAPD group,and the mean ultrafiltration volume three days before discharge was higher than that of the CAPD group(P＜0.05).The absolute differences in creatinine and blood potassium levels between discharge and admission in the APD group were higher than those in the CAPD group(P＜0.05).Conclusion:Compared with CAPD,APD is more effective in creatinine clearance and maintaining blood potassium balance in uremic patients with COVID-19 infection.Moreover,it can increase ultrafiltration volume and reduce hospitalization costs.
万方数据
维普
